Center For AIDS Research

October 28 - November 4, 2013

If you have problems viewing this email click here to open The Network News in your browser.
The Network News
October 28 - November 4, 2013
Divider RuleQuote of the Day...

What does a Southern Ghost say?

Boo Y'all!!

Divider RuleKudos...

     Emory Logo

... to Emory University for creating a centralized space for updates on how efforts to unravel the effect of the late, unlamented government shutdown continue to affect extramural research submission, review, and implementation.
Check out the Blog

Health Sciences Research Building    

... to Raymond Schinazi, the Georgia Research Alliance, and 13 other major donors whose financial generosity built the five-story, 200,000-square-foot Health Sciences Research Building that was dedicated on October 24.
Read More About It

Divider Rule In other news...

Happy Birthday

... to Brian Evavold (October 29), Colleen Kraft (October 30), Bob Mittler (November 2), and Galina Terbova (November 3)

God danced the day you were born
Angels did the bump to Gabriel's November 18horn
God danced the day you were born
So happy for the gift of you.
Happy Birthday!


Two notices from NIH...
First, the agency has extended by three weeks the amount of time to respond to NOT-OD-13-076: "Request for Information (RFI): Inviting Comments and Suggestions on the Health and Health Research Needs, Specific Health Issues and Concerns for Lesbian, Gay, Bisexual, Transgender, and Intersex (LGBTI) Populations." The new deadline is November 18.
Read More About It

Second, Heads Up... NIAID and NHLBI have announced that will be releasing a U19 FOA in winter 2014 to fund research in non drug-based approaches to eliminate HIV-1.
Get the Details

Marcia Holstad Ken Hepburn    

Marcia Holstad and Ken Hepburn have just been awarded new R13 funding from NIH/NIH. The conference, "HIV and Aging: From the Mitochonria to the Metropolis," is currently being planned for 2014 under the aegis of the CFAR HIV and Aging IRG.

Divider Rule Bulletin Board...

bulletin board

HIV Immunobiology Faculty Wanted: George Washington University
There are five newly established tenure track Assistant Professor faculty positions on offer in the Department of Microbiology, Immunology and Tropical Medicine at George Washington University, of which some will be focused on HIV immunobiology. Dr. Douglas Nixon has recently re-located to Washington DC to serve as Chair of this Department.
Read the Flyer

Divider Rule

Funding Opps

November 12 (App)
Sponsor: Gates Foundation
Grand Challenge
Round 12

January 7 (App)
Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP)

Jan 8, 2014, May 8, Sept 9, Jan 8, 2015 (App)
Sponsor: NHLBI
Basic Research in the Pathogenesis of HIV-Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children

Jan 8, 2014, May 8, Sept 9, Jan 8, 2015 (App)
Sponsor: NHLBI
Clinical Research in the Prevention, Diagnosis, and Treatment of HIV-Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children

January 17 (App)
Sponsor: NCI; FIC
Sub-Saharan African Collaborative HIV and Cancer Consortia

March 7 (App)
Sponsor: NIAID
Pilot Clinical Trials to Eliminate the Latent HIV Reservoir

Standard AIDS Dates (App)
Sponsor: NCI
Research on Malignancies in the Context of HIV/AIDS



November 18 (App)
Sponsor: Emory
Multidisciplinary Team Project
Emory Global Health Institute 2014 Multidisciplinary Team Opportunities

Divider Rule pubs

Recent Pubs
that acknowledge the CFAR grant
(P30 AI050409)

Day CL, Tameris M, Mansoor N, van Rooyen M, de Kock M, Geldenhuys H, Erasmus M, Makhethe L, Hughes EJ, Gelderbloem S, Bollaerts A, Bourguignon P, Cohen J, DemoitiƩ MA, Mettens P, Moris P, Sadoff JC, Hawkridge A, Hussey GD, Mahomed H, Ofori-Anyinam O, Hanekom WA. Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults.
Am J Respir Crit Care Med. 2013 Aug 15;188(4):492-502.

Gao J, Fu H, Lin L, Nehl EJ, Wong FY, Zheng P. Newspaper coverage of HIV/AIDS in China from 2000 to 2010.
AIDS Care. 2013;25(9):1174-8.

Haddad L, Wall KM, Vwalika B, Khu NH, Brill I, Kilembe W, Stephenson R, Chomba E, Vwalika C, Tichacek A, Allen S. Contraceptive discontinuation and switching among couples receiving integrated HIV and family planning services in Lusaka, Zambia.
AIDS. 2013 Oct;27 Suppl 1:S93-S103.

Paredes R, Marconi VC, Lockman S, Abrams EJ, Kuhn L. Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomes.
J Infect Dis. 2013 Jun 15;207 Suppl 2:S93-100

Rosenberg ES, Rothenberg RB, Kleinbaum DG, Stephenson RB, Sullivan PS. The implications of respondent concurrency on sex partner risk in a national, web-based study of men who have sex with men in the United States.
J Acquir Immune Defic Syndr. 2013 Aug 1;63(4):514-21.

Calendar Upcoming Events

October 28
12:00 - 1:00pm
Estimation of the standardized risk difference and ratio in a competing risks framework: Application to injection drug use and progression to AIDS after initiation of antiretroviral therapy
Starring: Stephen R. Cole (UCLA CFAR)
Location: RSPH/GCR/RAR

October 28
MMG Seminar
Not Another Talk About H7N9: Basic Aspects of Influenza Evolution
Starring: Jonathan Yewdell (NIAID)
Location: Whitehead Auditorium

October 28
6:00 - 8:00
MSM Advisory Group Meeting
Location: Evolution Project, 583 Juniper St, 30308
Meeting Flyer

October 29
2:00 - 3:00pm
Special Presentation
Management of HCV and HBV in Egyptian children and high risk population groups
Starring: Manal El-Sayed, MD
    Ain Shams University, Cairo
Location: Health Sciences Research Building Auditorium
Host: Laboratory of Biochemical Pharmacology

October 29
Atlanta Science Advisory Town Hall Meeting
How do the Sequestration and NIH Budget Cuts Affect you and your Future Career? How Can we Advocate for a Better Future for Science?
Location: RSPH/CNR/Klamon Room

October 31
8:00 - 9:00am
ID Seminar
SAMHD1 and RNase H2: Unexpected Molecular Encounter between HIV Replication and Immune-Related Aicardi-Goutieres Syndrome
Starring: Baek Kim
Location: RSPH/GCR/RAR

November 3-6
31st Annal Symposium
Nonhuman Primate Models for AIDS
Host: Yerkes (Drs. Amara and Zola, Scientific Chairs)
Venue: JW Marriott Buckhead
Conference Website

Calendar Farther Down the Road
2013-2014 Keystone Symposia
Drug Discovery
Infectious Diseases
Structural Biology

November 20
Towards an AIDS-free Generation: Increasing HIV Treatment
Starring: Wafaa El-Sadr, MD, MPH
   Principal Investigator, HPTN
Focus: Everyone
Sponsor: HPTN; Black AIDS Institute
Webinar Flyer
Click Here to Register (Free)

November 21
Training Session
Making Friends with the Female Condom
Target Audience: Everyone
Sponsor: Emory Reproductive Health Assn
RSVP to Courtney Peters

January 13-14, 2014
4th HIV & Women Workshop
From Adolescence Through Menopause
Location: Washington, DC
Early Reg Deadline: November 1, 2013
Abstract Deadline: November 15
Submit an Abstract
Conference Flyer

January 30-31, 2014
CN Workshop: Conference
Inflammation and Chronic Hepatitis/HIV infections: Who is the Driver?
Location: Milan, Italy
Abstract Deadline:
December 10, 2013
Submit an Abstract

February 22, 2014
7:00am - 7:00pm
15th Annual African-American Outreach Initiative
Our Community, Our Responsibility
Location: Loudermilk Center

March 3-6, 2014
CROI 2014: Conference
Location: Boston, MA
Important Deadlines


Divider Rule Spotlight

Spotlight! | Next Blockbuster Drug: Sofosbuvir

HCV model

Hepatitis C virus (HCV) accounts for upwards of 10,000 or more deaths a year and is a particularly brutal killer of people with HIV.

For the lucky few who can afford it though, that threat may be history as soon as this December.

On Friday (10/25/13), a 15 member FDA virus advisory panel unanimously voted to recommend approval of Sofosbuvir, a Pharmasett drug that originated in Ray Schinazi's Laboratory of Biochemical Pharmacology.

Although the FDA is not required to follow their advisory panel's advice, it is likely that they will in this case since Sofosbuvir came close to curing 100% of the HCV patients participating in Phase III clinical trials.

100% is good.

100% is also expensive. Dr. Schinazi predicts that Gilead, who bought the rights to the drug from Pharmasett, may charge between $75,000 and $100,000 for the 12-week, 1-pill-a-day treatment.

Listen to the WABE story about Sofosbuvir


Divider Rule
CFAR logo

The Network News is a periodic email, detailing HIV/AIDS related events, funding opportunities, and achievements of CFAR members. If you have items that you wish to have included, please send them to us at by Friday of each week. Please put "The Network News" in the subject line.

The Network News is distributed to CFAR members by email every Monday. Except when it isn't.

Editor, Kimberley Sessions Hagen, EdD

Divider Rule
Emory University Center for AIDS Research Emory University Center for AIDS Research